Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent hiv-infected patients in Spain

Jordi Navarro, Merce Pérez, Adria Curran, Joaquin Burgos, Maria Feijoo, Ariadna Torrella, Estrella Caballero, Inma Ocaña, Esteban Ribera, Manel Crespo, Vicenç Falcó

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Abstract

© 2014 Mary Ann Liebert, Inc. Several studies have shown the importance of adherence to highly active antiretroviral therapy (HAART) in achieving HIV-1 suppression. However, most have focused on naïve patients and do not assess the impact of HAART on viral load (VL). Our aim was to evaluate the effectiveness of an adherence program in a cohort of multitreated and poorly adherent patients. We performed a cohort study of all adult HIV-1 infected patients with detectable VL who were treatment experienced and poorly adherent to HAART, included in an adherence program since its introduction in 2009 (n=136). The adherence program consisted of a multidisciplinary team with a nurse who specialized in behavioral intervention, counselling on substance abuse, and motivational interviewing, as well as a social worker responsible for referring patients to local healthcare centers. Effectiveness was evaluated as percentage of patients with VL <50 copies/mL at week 48 by modified intent-to-treat (mITT) analysis. Initially, 76.6% of the patients had an adherence <30% according to the Simplified Medication Adherence Questionnaire (SMAQ). At 48 weeks, 48.1% of the patients had VL <50 copies/mL, and the adherence was >90% in 71% of the patients. In multivariate analysis, a ratio of bottle refill per month >0.9 during the study [odds ratio (OR) 14.3; 95% confidence interval (CI) 4.08-50.08, p<0.001] and being on a b.i.d. regimen (OR 12.5; 95% CI 1.81-86.4, p=0.010) were associated with an undetectable VL. In conclusion, the adherence program was successful in almost half of the patients, despite their long treatment experience and prior poor adherence. This strategy may help to prevent disease progression and the risk of HIV transmission in these patients.
Original languageEnglish
Pages (from-to)537-542
JournalAIDS Patient Care and STDs
Volume28
Issue number10
DOIs
Publication statusPublished - 1 Jan 2014

Fingerprint Dive into the research topics of 'Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent hiv-infected patients in Spain'. Together they form a unique fingerprint.

Cite this